Skip to content

Effect of 4 Weeks Fish Oil Supplementation on Cycling Performance in Healthy Male Cyclists

Effect of 4 Weeks Fish Oil Supplementation on Cycling Performance or Oxidative and Inflammatory Parameters in Healthy Male Cyclists

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03205241
Enrollment
12
Registered
2017-07-02
Start date
2014-04-30
Completion date
2014-12-31
Last updated
2017-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Exercise-induced Inflammation

Keywords

Exercise, Fish Oil, Cycling, Inflammation, Oxidative stress

Brief summary

Research Plan Eleven trained cyclists have completed 4 cycling performance trials, before and after 4 weeks of fish oil supplementation and before and after 4 weeks of placebo with a 4 week washout between supplementation periods. During the performance trials blood, expired air and heart rate were collected. The blood samples have been used to investigate the production of inflammation resulting from the cycling performance test. Inflammation has been assessed using enzyme-linked immunosorbent assay for IL-6, which is an inflammatory cytokine. Work done from the cycling performance will be analysed to investigate whether there is a relationship with power and inflammation and whether this is modulated by fish oil supplementation. Specific Aims 1. Does 4 weeks of Fish Oil supplementation attenuate the inflammatory response following high intensity cycling. 2. Is a modulation of the inflammatory response connected to cycling performance. Hypotheses 1. Four weeks of n3-PUFA supplementation will reduce the inflammatory response 2. A reduction in inflammation will improve cycling performance Anticipated Outcomes A high level of cycling performance, indicated by a high average power, will be associated with high levels of systemic inflammation. n3-PUFA supplementation will decrease the level of inflammation and consequently cycling performance will be improved.

Interventions

DIETARY_SUPPLEMENTn-3 PUFA

n-3 PUFA capsules containing EPA and DHA

DIETARY_SUPPLEMENTPlacebo

Olive oil capsules

Sponsors

University of Worcester
CollaboratorOTHER
Loughborough University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Randomised, placebo-controlled, double blind, crossover design study

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* recreationally trained male cyclists

Exclusion criteria

* History of coagulation/bleeding disorder * History of metabolic disease * Serious allergy * History of heart disease * Regular use of anti-inflammatory drugs * Vitamin or fish oil supplementation over the past 6 months * Known to have blood-borne virus * Females

Design outcomes

Primary

MeasureTime frameDescription
Work Done15 minutes during time trialWork done measured in Joules from the Lode cycle ergometer during 15 minute cycling time trial

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026